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Highlights 
 Silver nanoparticles (AgNPs) show higher biocompatibility compared to the 
chemically-synthesized ones. 
 The TEM images showed that AgNPs were surrounded by an irregular cove-
rage.  
 The IR spectrum showed that this coverage was composed of carbohydrates 
and/or proteins. 
 Different proteins were identified in the capping associated to biosynthesi-
zed AgNPs. 
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ABSTRACT 
The development of environmental friendly new procedures for the synthesis of 
metallic nanoparticles is one of the main objectives of nanotechnology. Plants, algae, fungi 
and bacteria for the production of nanomaterials are viable alternatives due to their low 
cost, the absence of toxic waste production and their highly energy efficiency. It is also 
known that biosynthesized silver nanoparticles (AgNPs) show higher biocompatibility 
compared to the chemically-synthesized ones. In previous results, biosynthesized AgNPs 
were obtained from the supernatant of Pseudomonas aeruginosa, and they showed a bigger 
antimicrobial activity against different bacterial species compared to the chemically-
synthesized ones. The aim of this work was to analyze the capping of biosynthesized 
AgNPs using techniques such as transmission electron microscopy (TEM), infrared 
spectroscopy (IR), and protein identification through mass spectrometry (MS) in order to 
identify the compounds responsible for their formation, stability and biocompatibility. The 
TEM images showed that AgNPs were surrounded by an irregular coverage. The IR 
spectrum showed that this coverage was composed of carbohydrates and/or proteins. 
Different proteins were identified in the capping associated to biosynthesized AgNPs. Some 
proteins seem to be important for their formation (Alkyl hydroperoxide reductase and 
Azurin) and stabilization (Outer membrane protein OprG and Glycine zipper 2TM domain-
containing protein). The proteins identified with the capability to interact with some 
biomolecules can be responsible for the biocompatibility and may be responsible for the 
bigger antimicrobial activity than AgNPs have previously shown. These results are pioneers 
in the identification of proteins in the capping of biosynthesized AgNPs. 
 
KEYWORDS: bacteria, silver nanoparticles, capping, proteins. 
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1. INTRODUCTION 
Great advances in nanoscience had exposed the excellent physical and chemical 
properties of matter at nanometric size and its differences with the macro/micrometric state. 
The green synthesis of nanoparticles (NPs) consists in the use of plants, algae, fungi or 
bacteria for the production of low-cost, energy-efficient and non-toxic nanomaterials [1,2].  
The biosynthesis of NPs has become an important object of study for nanotechnology, due 
to the great number of advantages that it offers. Chemical methods have some weaknesses 
that include the use of toxic solvents, the generation of dangerous by-products and the high 
consumption of energy [3]. When a particle decreases in size, a greater proportion of the 
atoms are present on its surface compared to the interior. These particular characteristics of 
nanoparticles improve the interaction with other molecules. The surface/volume ratio of the 
nanoparticles is big, which gives them an excellent capacity to adsorb substances. This 
property makes them good carriers of other molecules, such as chemical compounds, drugs, 
probes and proteins attached to the surface [3]. Biosynthesized NPs are more acceptable for 
medical applications because they offer biocompatibility superior to NPs produced by 
chemical methods [4]. This biocompatibility would be mediated by the biomolecules that 
act as natural stabilizers of NPs, preventing not only the aggregation over time but also 
giving them a particular additional stabilization [5]. The biomolecules that form part of the 
coverage would mediate the interaction with other biological molecules (proteins, sugars or 
even whole cells) and could improve the interaction with the pathogens involved5. This 
particular property could be responsible for the best antimicrobial activity of the NPs with 
respect to the NPs synthesized by other methods [1, 6-10] . However, there are no studies 
devoted to the identification of compounds such as proteins present in the capping of the 
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biosynthesized NPs. 
In previous studies, our group reported a simple and green method for the biological 
synthesis of AgNPs using a cell-free supernatant of Pseudomonas aeruginosa. These 
biosynthesized AgNPs were stable, uniform, spherical and showed a great antimicrobial 
activity at picomolar levels against representative human Gram-positive and Gram-negative 
pathogens including multi-drug resistant bacteria such as methicillin-resistant 
Staphylococcus aureus, Acinetobacter baumannii and Escherichia coli [11]. 
The main objective of this work was to analyze the coverage of biosynthesized 
silver nanoparticles (AgNPs) to determine which components would be involved in the 
synthesis of the NPs and would be responsible for their stability and for the antimicrobial 
activity they previously showed. 
 
2. MATERIALS AND METHODS 
2.1. Chemicals and reagents 
Luria Bertani medium (MP Biomedicals, France), Mueller Hinton medium 
(Britania, Argentina). Silver nitrate (AgNO3), potassium bromide (KBr), Phosphate Buffer 
Solution (PBS): sodium chloride (NaCl), potassium chloride (KCl), Sodium phosphate di-
basic (Na2HPO4), potassium phosphate monobasic (KH2PO4); Ethylenediaminetetraacetic 
acid (EDTA); Ethanol and Formaldehyde from Cicarelli (Argentina). Bradford Reagent 
(Bio-Rad). Bis-acrylamide and acrylamide, Bovine serum albumin (BSA), Tris, Glycine, 
Sodium dodecyl sulfate (SDS), Ammonium persulfate (APS) and N,N,N',N'- 
Tetramethylethylenediamine (TEMED) from Sigma-Aldrich. Hydrochloric acid, Acetic 
acid, Sodium thiosulfate, Sodium acetate, and Sodium carbonate from Tetrahedron 
(Argentina). 
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2.2. Biosynthesis of AgNPs  
In previous studies, a satisfactory methodology was developed to obtain stable 
nanoparticles with uniform size and shaping [11]. A culture of Pseudomonas aeruginosa 
ATCC 27853 was carried out in liquid LB medium at 37°C for 24 h. The culture was 
centrifuged at 10000 xg for the elimination of the biomass and the obtained supernatant was 
filtered. 10 mM silver nitrate solution (70:30 ratio) was added to one aliquot of the obtained 
supernatant. The resulting solution was incubated at 37 °C for 24 h with agitation and 
darkness. After the incubation time, the UV-vis absorption spectrum of the obtained 
solution was carried out, which indicated the formation of AgNPs by the appearance of 
surface plasmon resonance (SPR) at 412 nm. 
 
2.3 Characterization by TEM 
The morphological analysis of the AgNPs was carried out using a microscope at 
JEM-JEOL 1120 EXII operated at 80 kV. 10 μL of the biosynthesized samples were taken 
and placed on a grid for carbon-coated carbon microscopy. The samples were dried at room 
temperature and in darkness [12]. 
 
2.4 Infrared spectroscopy (IR) 
Samples were prepared following the potassium bromide disk method (solid phase 
method) and then lyophilized. 50 mg of potassium bromide were added to 2 mg of the solid 
sample, and they were pulverized in an agate mortar, being careful with moisture 
absorption [13]. The mixture was compressed in a suitable mold for the formation of the IR 
discs. Not-uniform discs obtained were discarded for the analysis. The samples were 
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analyzed in an FT-IR team (Avatar 360). 
2.5 Characterization of AgNPs corona 
In addition to the results obtained by using TEM and IR, AgNPs corona 
composition was analyzed by identifying the proteins presents. 
2.5.1 Sample Preparation 
After incubation with Ag+ ions, cell-free supernatant of P. aeruginosa used for the 
AgNPs biosynthesis was centrifuged for the AgNPs precipitation and the supernatant was 
removed.  AgNPs were re-suspended in mQH2O. Additionally, the proteins of the cell-free 
supernatant without the incubation with Ag+ were also analyzed. 
2.5.2 Electrophoresis 
The total protein concentration of the supernatants was determined by the Bradford 
method, using BSA as reference (0-10 μg mL-1) [14]. Proteins were concentrated by 
precipitation with cold acetone and were re-suspended in Urea-Thiourea-CHAPS buffer. 15 
µg of proteins were placed into the wells. Finally, the electrophoresis under denaturing 
conditions (SDS-PAGE) in a gel prepared at 12% was performed at constant 180v for 2h 
[15]. The gel was stained by using a silver staining MS-compatible procedure. The 
visualized bands were excised from the gel and conserved in mQH2O for the protein 
identification analysis. 
2.5.3 Protein identification analysis 
Samples were reduced with 20 mM DTT for 45 min at 56 °C and were alkylated 
with 20 mM Iodoacetamide for 45 min. Proteins were in-gel digested using sequencing 
grade Trypsin. The extraction of the peptides was carried out with acetonitrile. Samples 
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were lyophilized by Speed Vac and re-suspended with 10 µL of 0.1% Formic Acid. 
Peptides were separated by nanoHPLC (EASY-nLC 1000, Thermo Scientific) and were 
analyzed by tandem mass spectrometry (spectrometer Q-Exactive, Thermo Scientific) with 
Orbitrap technology (nanoHPLC-ESI-MS/MS). 
The bioinformatics analysis of the data obtained was performed with the Proteome 
Discoverer v1.4 software (Thermo Scientific), using the specific database for P. 
aeruginosa. 
 2.6. Statistical analysis 
The assays were performed in triplicate. Data were expressed as means ± SD.  
 
3. RESULTS  
3.1 Synthesis and Characterization of AgNPs by TEM 
The TEM technique was used to visualize the shape and size of the AgNPs obtained 
by P. aeruginosa supernatant. The AgNPs showed a homogeneous distribution in size and 
shape. They were spheroidal and the size was 25 nm ±8 nm. The TEM images revealed that 
AgNPs were surrounded by a corona, which was probably made up of components of the 
supernatant of the culture of P. aeruginosa (Figure 1).  
 
3.2. Characterization of AgNPs by IR 
Bacteria supernatant and AgNPs were both analyzed by IR.  In the supernatant 
sample, peaks at 3,417 cm-1 were observed and they could correspond to the presence of 
amide groups (voltage vibrations of the N-H bond). Other peaks were also observed, such 
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as 1,663 cm-1 (vibrations of the link voltage C=0), 1,401 cm-1 (bending vibration of C-OH) 
and 1,074 cm-1 (vibration of the C-O-C bond in polysaccharide groups). The appearance of 
these characteristic peaks suggests the presence of carbohydrates and proteins in bacteria 
supernatant (Figure 2A). 
In the AgNPs spectrum, some differences were noticed with respect to the 
supernatant sample. Some decreases and increases were observed in the peaks described 
previously (Figure 2B). The decrease of the peak at 3,417 cm-1 could be considered as the 
main factor that acts as a reducer in the synthesis reaction. Likewise, the increase of the 
peak at 1,401 cm-1 could be part of the stabilizing agent in AgNPs.  
 
3.3 Characterization of AgNPs corona 
In addition to the results obtained by using TEM and IR, AgNPs corona 
composition was analyzed by identifying the proteins present in AgNPs.   
After the SDS-PAGE, eight bands were visualized in the gel: two bands were 
observed in the lane corresponding to the cell-free supernatant without the incubation with 
Ag+ ions, while six bands were observed in the lane corresponding to biosynthesized 
AgNPs (Figure 3). In addition, it could be seen that the concentration of some of the 
proteins was higher in the AgNPs sample (NP03 - 08). The increase observed in the AgNPs 
bands could be due to a greater affinity of proteins of P. aeruginosa supernatant by the 
AgNPs surface. 
Table 1 show the proteins presents in the surface of AgNPs biosynthesized. From 
MS analysis of the excised bands, 20 proteins were identified. It is important to highlight 
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that most of the proteins were identified in AgNPs sample, while only one protein was 
identified from the crude supernatant sample. Unfortunately, proteins from bands No 2 and 
5 could not be identified. 
The proteins identified in bands corresponding to AgNPs sample were classified 
according to their function registered in the Uniprot database. Among proteins, we found 
outer membrane structural proteins, such as Outer membrane protein OprG and Glycine 
zipper 2TM domain-containing protein; proteins of interactions with biomolecules, namely 
Phospholipid-binding protein MlaC, PhoP/Q and low Mg2+ inducible outer membrane 
protein H1 (interaction with lipopolysaccharide), Uncharacterized protein PA1579 (lipid 
binding), Azurin (interaction with transition metal ions), cold-shock protein (interaction 
with nucleic acids), Bacteriohemerythrin (metal binding); proteins characteristics of 
response to oxidative and environmental stress, such as Alkyl hydroperoxide reductase 
subunit C and RNA-binding protein Hfq; and important proteins involved in metabolic 
reactions, e.g. Inorganic pyrophosphatase, Lipid A deacylase PagL, Pterin-4-alpha-
carbinolamine dehydratase, Glycine cleavage system H protein 1 and YgdI/YgdR family 
lipoprotein. 
 
4. DISCUSSION 
The most important challenge in the synthesis processes is to obtain stable NPs with 
uniform size and shape. The chemical synthesis of NPs generally occurs under extreme 
conditions of pH or temperature, and the chemicals substances used can have a negative 
impact on health and the environment [16]. The use of microorganisms in the synthesis of 
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NPs is a relatively new promising research area, with a potential for considerable 
expansion. Biosynthesis has as main advantages, a lower use of energy and little 
environmental impact, compared to conventional methods [16-18]. Imtiyaz Hussain [19] 
summarizes the benefits of the biosynthesis like a low cost and high energy-efficiency 
process with absence of toxic waste or use of organic solvents. Currently, the precise 
mechanism of NP synthesis by biological agents is under study. This is because each type 
of agent reacts differently to the metals that lead to the formation of NPs [19].  
There are many studies that support that biogenic NPs have a better antimicrobial 
activity compared to those of chemical origin. Sintubin et al. [20] demonstrated that the 
biosynthesized NPs had an antimicrobial activity 20 times bigger than those chemically 
synthesized. Botes and Cloete [21] propose that this is due to the fact that biological 
molecules not only give stability to NPs but also significantly increase the interaction with 
microorganisms, fostering their antimicrobial activity.  
The biomolecules involved in the biosynthesis process give the AgNPs a differential 
stability due to the capping function it performs. One of the possibilities offered by 
biosynthesis is the use of fungi members. Some authors showed that the synthesis of NPs 
from fungi gives rise to AgNPs with excellent antibacterial activity. However, the main 
disadvantage is that the methodology involves numerous steps and longer time in which, in 
some cases, obtaining NPs can take up to 5 days of incubation [22-24]. The use of bacteria 
(in this case, the P. aeruginosa supernatant) as a route of production of AgNPs is more 
advantageous than other microorganisms, since the time of synthesis takes usually only a 
few hours [25-27].  
Ahmed et al. [28] proposed the possible capping mechanism of the nanoparticles 
using FTIR studies in fungi. To determine the interaction between the biopolymer (Levan) 
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and NP, this group compared the FTIR spectra of Levan and stabilized AgNPs with this 
biopolymer. The IR peaks at 1650 cm-1 and 3400 cm-1, which are characteristic of the 
carbonyl and hydroxyl groups respectively, were present in both the Levan AgNPs 
spectrum and the Levan stabilized, indicating the presence of this biopolymer around the 
particles. These results are in accordance with the IR analysis obtained in this work, where 
the carbonyl and hydroxyl groups are present in AgNPs and in the supernatant of P. 
aeruginosa. This indicates the participation of components of the supernatant of the 
bacteria in the formation of nanoparticles. 
According to the literature, numerous studies have shown that the NPs stability can 
be achieved by the interaction of proteins on its surface, forming a complex called corona 
protein [29-32]. The initial corona that forms on the surface of the nanoparticle, the “hard 
corona” (HC), consists of proteins with high association rates. By contrast, the proteins that 
constitute the soft corona (SC) quickly exchanged the surrounding environment in short 
timescales [33]. The HC is considered to play an important role in the interaction of the 
nanoparticles with their surrounding cells since it is more stable and closely associated with 
the surface of the nanomaterial.  
In thermodynamic terms, Walkey et al. explains the interaction of the nanoparticle 
with the protein corona. They affirm that the HC adsorbs onto the surface of NPs in a 
thermodynamically favorable manner with a large net binding energy of adsorption 
(ΔGads). This binding energy determines the stability of the protein–nanomaterial complex, 
as a consequence, proteins that adsorb with a large ΔGads have a low probability of 
desorption and tend to stay associated with the nanomaterial [34]. The proteins that adsorb 
with a small ΔGads, easily desorb and return to solution, as in the case of SC [34]. 
In other hand, a work published by Jain et al. [35], bands corresponding to two 
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proteins of 32 and 35 kDa were observed by SDS-PAGE. However, these proteins were not 
identified and the authors concluded that the proteins would have the function of reducing 
agents and capping. In the same line of research, Elumalai et al. [36] assumed that AgNPs 
synthesized using the coconut water were surrounded by some proteins and metabolites 
such as terpenoids and flavonoids, which are capping ligands of the nanoparticles.  
To the best of our knowledge, there are no works devoted to the identification of the 
proteins which can be part of the corona surrounding the NPs synthetized by biological 
methods.  In this work, the information obtained from the electrophoresis analysis was 
completed with the data acquired from the nanoHPLC-ESI-MS/MS studies followed by 
bioinformatics analysis to identify the proteins from the P. aeruginosa supernatant. 
Different proteins were identified in the corona associated to AgNPs biosynthesized. The 
presence of a bigger number of bands in the AgNPs sample could indicate that the proteins 
were concentrated around the nanoparticles and were precipitated after centrifugation. 
Therefore, we are not able to see these proteins in the crude supernatant sample, indicating 
that these proteins were present in very low concentration in the extracellular medium and 
the sensitivity of the silver staining method is not enough to reveal the bands of these 
proteins. Among the identified proteins, some proteins seem to be important for the 
formation, stabilization and interaction with some of the bacterial species tested in previous 
studies [11]. Some authors claim that the amount of proteins plays an important role in 
controlling the size and shape of the nanoparticles. Sotnikov et al. [37] asseverate that the 
interaction of macromolecules with nanoparticles depends on several factors, including the 
chemical nature of the adsorbed material, the composition of the medium, the pH, among 
others. The extracellular proteins also act as a capping agent stabilizing the particles [38]. 
Alkyl hydroperoxide reductase possesses a reductase function and it is one of the 
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proteins which could be responsible for the reduction of Ag+ ions into Ag0 in the AgNPs. 
Azurin is a protein with interactions to transition metal ions like silver and, at the same 
time, this protein had demonstrated to be capable of transfering electrons, both being 
responsible for the formation of AgNPs. The interaction between azurin and silver 
nanomaterials was studied by some authors, such as Martinolich et al. [39], who 
demonstrated that NP interactions impacted on protein structure, function, and modified the 
NP reactivity with implications for targeting, uptake, and cytotoxicity. Similarly, Freitas et 
al. [40] studied the alteration of the 10-40 nm Ag engineered nanomaterial (ENM) surface 
by adsorbed Azurin. The results showed an adventitious protein-ENM redox reaction that 
altered both metal ENM and protein reactivity [40]. Xie et al. [41] used an algal extract 
solution to produce single-crystalline gold nanoplates and demonstrated the presence of 
proteins involved in the synthesis of the gold nanoplates. A protein of 28 kDa called gold 
shape-directing protein (GSP) was isolated and purified by RP-HPLC and was found to 
possess both reduction and shape-directing functionalities. In a review published in 2016, 
the authors highlighted the importance of microbial cellular and extracellular 
oxidoreductase enzymes in the reduction processes for the formation of AgNPs. 
Additionally, these authors concluded that those reducing agents or other constituents 
present in the cells act as stabilizing and capping agents [42].  
Some of the proteins that can be involved in the stability of the NPs are the 
identified structural proteins like Outer membrane protein OprG and Glycine zipper 2TM 
domain-containing protein. Likewise, the proteins identified with capability to interact with 
some biomolecules can be responsible for the biocompatibility and may be responsible for 
the bigger antimicrobial activity that biosynthesized AgNPs have previously shown 
compared to the chemically-synthesized AgNPs [11]. Among these proteins, we can 
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mention the following proteins: cold-shock protein, uncharacterized protein PA1579, 
Phospholipid-binding protein MlaC and PhoP/Q and low Mg2+ inducible outer membrane 
protein H1. 
 
5. CONCLUSION 
These results pioneer the identification of proteins in the capping of biosynthesized 
AgNPs. Some proteins seem to be important for their formation (Alkyl hydroperoxide 
reductase and Azurin) and stabilization (Outer membrane protein OprG and Glycine zipper 
2TM domain-containing protein). The proteins identified with the capability to interact with 
some biomolecules can be responsible for the biocompatibility and may be responsible for 
the bigger antimicrobial activity of AgNPs biosynthesized extracellularly by P. aeruginosa. 
This is of great interest not only because it allows understand the biogenic synthesis 
of the AgNPs obtained from the supernatant of the bacteria, but also highlights because it 
provides relevant information in the identification of those proteins that make up the corona 
around the AgNPs. It is very important to know the nature of the protein corona in biogenic 
NPs since it represents the “way in which the cells see the particle” [43]. 
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CAPTIONS 
 
FIGURE 1. TEM image of biosynthesized AgNPs: A) scale 50 nm 500,000X B) scale 200 
nm 150,000X. 
FIGURE 1.  Quinteros et al. 
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FIGURE 2. (A) IR spectrum of P. aeruginosa supernatant and (B) IR spectrum of AgNPs. 
 FIGURE 2.  Quinteros et al. 
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FIGURE 3. SDS-PAGE gel obtained from P. aeruginosa supernatant (lane 1) and AgNPs 
sample (lane 2). 
FIGURE 3.  Quinteros et al. 
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Table 1. Proteins identified from excised bands of the gel applying nanoHPLC coupled to 
MS/MS analysis. 
Table 1. Quinteros et al. 
Band 
number 
Accession Description Coverage 
(%) 
Peptides MW 
[kDa] 
calculated 
pI 
Score 
Sequest 
HT 
S01 Q9I690 UPF0312 protein PA0423 4,71 1 20,8 6,55 2,04 
S02  Unidentified 
 
    
NP03 Q9HWW1 Outer membrane protein OprG 12,93 2 25,2 5,12 4,45 
 Q9HVW4 Phospholipid-binding protein MlaC 11,63 2 23,7 9,14 5,42 
NP04 G3XD11 PhoP/Q and low Mg2+ inducible 
outer membrane protein H1 27,00 
5 21,6 9,03 21,68 
 Q9I690 UPF0312 protein PA0423 25,65 4 20,8 6,55 14,31 
 Q9HWZ6 Inorganic pyrophosphatase 6,29 1 19,4 5,25 4,57 
 Q9I6Z3 Alkyl hydroperoxide reductase 
subunit C 5,35 
1 20,5 6,33 2,16 
 Q9I3D8 Uncharacterized protein PA1579 10,89 2 22,1 7,94 4,1 
NP05  Unidentified 
 
    
NP06 P00282 Azurin 12,16 2 16 6,92 8,82 
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 Q9HVD1 Lipid A deacylase PagL 8,67 1 18,4 6,3 3,37 
 Q9I4S1 Glycine zipper 2TM domain-
containing protein 20,78 
2 15,6 9,61 8,04 
NP07 Q9I6G2 UPF0339 protein PA0329 10,00 1 11,8 9,28 2,51 
 P43335 Pterin-4-alpha-carbinolamine 
dehydratase 13,56 
1 13,3 6,4 2,51 
 Q9I136 Glycine cleavage system H protein 1 7,09 1 13,8 4,3 2,23 
 Q9HTL9 RidA family protein 39,68 4 13,6 5,15 16,73 
 Q9HY15 Uncharacterized protein 11,76 2 15 8,65 4,18 
NP08 Q9I4H8 Probable cold-shock protein 44,93 3 7,7 7,42 13,58 
 Q9I352 Bacteriohemerythrin 7,84 1 17,8 6,21 1,95 
 Q9HUM0 RNA-binding protein Hfq 15,85 1 9,1 9,52 1,94 
 Q9I129 YgdI/YgdR family lipoprotein 12,33 1 8,1 8,18 2,22 
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